Prot #BST005: A Phase I/II Dose Escalation and Expansion Study of BST-236 plus Venetoclax in Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Induction Chemotherapy

Project: Research project

Project Details

StatusActive
Effective start/end date8/11/228/11/25

Funding

  • Pharmaceutical Research Associates, Inc. ((OE) Prot #BST005 // (OE) Prot #BST005)
  • BioSight Ltd. ((OE) Prot #BST005 // (OE) Prot #BST005)